Generic placeholder image

Current Neurovascular Research

Author(s): Qiulan Li, Yanping Gao, Jie Zhu and Qingzhe Jia*

DOI: 10.2174/1567202617666200211113016

DownloadDownload PDF Flyer Cite As
MiR-101 Attenuates Myocardial Infarction-induced Injury by Targeting DDIT4 to Regulate Autophagy

Page: [123 - 130] Pages: 8

  • * (Excluding Mailing and Handling)

Abstract

Background: Myocardial Infarction (MI), a kind of heart deficiency, is the main cause of death and disability. Autophagy, a metabolic process for the degradation of damaged proteins or organelles, is important for cardiac functions and regulated by several miRNAs including miRNA- 101. The aim of this research was to investigate the effects of miR-101 in myocardial infarctioninduced injury and the related mechanisms.

Methods: MI model was induced by ligation of the left coronary artery. The in vitro model was established by hypoxia-induced H9c2 cells (rat myocardial cells). The overexpression of miR-101 was achieved by transfection. The expression of associated proteins was analyzed by Western blotting. The level of miR-101 was analyzed by reverse transcription-polymerase chain reaction (RTPCR). The target genes for miR-101 and the target sites were analyzed by TargetScan.

Results: The results showed that miR-101 was decreased in MI mice (P<0.01). Autophagy and apoptosis were increased in MI-induced injury (in vivo) and in hypoxia treated myocardial cells (in vitro) (P<0.01). miR-101 overexpression inhibited the increase of autophagy and apoptosis in mice and myocardial cells (P<0.01). DDIT4 was a target gene of miR-101 and expressed increasingly in MI-induced injury mice and hypoxia treated myocardial cells. miR-101 could negatively regulate the expression of DDIT4.

Conclusion: This research suggested that miR-101 attenuated- MI-induced injury by targeting DDIT4 to regulate autophagy, which indicated that miR-101 or DDIT4 may be potential therapeutic targets for heart injury.

Keywords: miRNA-101, myocardial infarction-induced injury, DNA damage-inducible transcript 4, autophagy, tissue, heart.

[1]
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction 2018; 72(18): 2231-64.
[http://dx.doi.org/10.1093/eurheartj/ehy655]
[2]
O'gara PT, Kushner FG, Ascheim DD, et al. ACCF/AHA guideline for the management of ST-elevation myocardial infarction: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2013; 61(4): 485-510.
[3]
Wu D, Zhang K. The role of autophagy in acute myocardial infarction 2019; 10: 551.
[4]
Nishida K, Kyoi S, Yamaguchi O, Sadoshima J, Otsu K. The role of autophagy in the heart. Cell Death Differ 2009; 16(1): 31-8.
[http://dx.doi.org/10.1038/cdd.2008.163] [PMID: 19008922]
[5]
Zhang YJ, Yang SH, Li MH, et al. Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy 2014; 41(12): 995-1002.
[http://dx.doi.org/10.1111/1440-1681.12309]
[6]
Kanamori H, Takemura G, Goto K, et al. Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway 2013; 182(3): 701-13.
[http://dx.doi.org/10.1016/j.ajpath.2012.11.009]
[7]
Lin C, Liu Z, Lu Y, et al. Cardioprotective effect of Salvianolic acid B on acute myocardial infarction by promoting autophagy and neovascularization and inhibiting apoptosis 2016; 68(7): 941-52.
[http://dx.doi.org/10.1111/jphp.12567]
[8]
Matsui Y, Takagi H, Qu X, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007; 100(6): 914-22.
[http://dx.doi.org/10.1161/01.RES.0000261924.76669.36] [PMID: 17332429]
[9]
Chistiakov DA, Orekhov AN. Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction) 2016; 94: 107-21.
[10]
Grabmaier U, Clauss S, Gross L, et al. Diagnostic and prognostic value of miR-1 and miR-29b on adverse ventricular remodeling after acute myocardial infarction- The SITAGRAMI-miR analysis. Int J Cardiol 2017; 244: 30-6.
[http://dx.doi.org/10.1016/j.ijcard.2017.06.054] [PMID: 28663047]
[11]
Huang D, Wang X, Zhuang C, et al. Reciprocal negative feedback loop between EZH2 and miR-101-1 contributes to miR-101 deregulation in hepatocellular carcinoma 2016; 35(2): 1083-90.
[http://dx.doi.org/10.3892/or.2015.4467]
[12]
Chen D-l, Ju H-q, Lu Y-x, et al. Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression 2016; 35(1): 142.
[http://dx.doi.org/10.1186/s13046-016-0420-1]
[13]
Zhou X, Xia Y, Li L, et al. MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2 2015; 16(1): 160-9.
[14]
Frankel LB, Wen J, Lees M, et al. microRNA-101 is a potent inhibitor of autophagy 2011; 30(22): 4628-1.
[15]
Chen L, Jia J, Zang Y, et al. MicroRNA-101 regulates autophagy, proliferation and apoptosis via targeting EZH2 in laryngeal squamous cell carcinoma. Neoplasma 2019; 66(4): 507-15.
[16]
Sun P, Song SZ, Jiang S, et al. Salidroside Regulates Inflammatory Response in Raw 264.7 Macrophages via TLR4/TAK1 and Ameliorates Inflammation in Alcohol Binge Drinking-Induced Liver Injury. Molecules 2016; 21(11): 1490.
[http://dx.doi.org/10.3390/molecules21111490] [PMID: 27834881]
[17]
Liu Y-H, Xu J, Yang X-P, et al. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure 2002; 39(2): 375-81.
[http://dx.doi.org/10.1161/hy02t2.102796]
[18]
Pan Z, Sun X, Shan H, et al. MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway. Circulation 2012; 126(7): 840-50.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.112.094524] [PMID: 22811578]
[19]
Yan D, Ng WL, Zhang X, et al. Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One 2010; 5(7) e11397
[http://dx.doi.org/10.1371/journal.pone.0011397] [PMID: 20617180]
[20]
Santana AE, Taborda CP, Severo JS, et al. Development of enzyme immunoassays (ELISA and Western blot) for the serological diagnosis of dermatophytosis in symptomatic and asymptomatic cats Med Mycol 2018; 56(1): 95-102.
[21]
Zhu K, Liu D, Lai H, et al. Developing miRNA therapeutics for cardiac repair in ischemic heart disease 2016; 8(9): E918.
[http://dx.doi.org/10.21037/jtd.2016.08.93]
[22]
Wang G-K, Zhu J-Q, Zhang J-T, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans 2010; 31(6): 659-.
[http://dx.doi.org/10.1093/eurheartj/ehq013]
[23]
Dong H, Sun Y, Shan F, Sun Q, Yang B. Down-Regulation of miR-101 Contributes to Rheumatic Heart Disease Through Up-Regulating TLR2. Med Sci Monit 2015; 21: 1500-6.
[http://dx.doi.org/10.12659/MSM.893540] [PMID: 26022377]
[24]
Zhao X, Wang K, Hu F, et al. MicroRNA-101 protects cardiac fibroblasts from hypoxia-induced apoptosis via inhibition of the TGF-β signaling pathway. Int J Biochem Cell Biol 2015; 65: 155-64.
[http://dx.doi.org/10.1016/j.biocel.2015.06.005] [PMID: 26055514]
[25]
Zhang Z, Yang M, Wang Y, et al. Autophagy regulates the apoptosis of bone marrow-derived mesenchymal stem cells under hypoxic condition via AMP-activated protein kinase/mammalian target of rapamycin pathway 2016; 40(6): 671-85.
[26]
Fu H, Li X. NIPAAm-MMA nanoparticle-encapsulated visnagin ameliorates myocardial ischemia/reperfusion injury through the promotion of autophagy and the inhibition of apoptosis 2018; 15(4): 4827-36.
[27]
Lu J, Pan S-S, Wang Q-T, et al. Alterations of cardiac KATP channels and autophagy contribute in the late cardioprotective phase of exercise preconditioning 2018; 59(5): 1106-5.
[28]
Frankel LB, Wen J, Lees M, et al. microRNA-101 is a potent inhibitor of autophagy 2011; 30(22): 4628-1.